๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A synthetic approach to the pseudopterosins using cascade technology

โœ Scribed by David C. Harrowven; Shelagh T. Dennison; Peter Howes

Book ID
104214387
Publisher
Elsevier Science
Year
1994
Tongue
French
Weight
294 KB
Volume
35
Category
Article
ISSN
0040-4039

No coin nor oath required. For personal study only.

โœฆ Synopsis

A rapid synthetir entry towards the pseudoprerosins. o class of dilerpenes which display parent anti-

in@mmatory and analgesic properties, is described. The key feature of this approach is the use of a sequential intromolerular, bwis arid mediared Fried4CrojIs alkylnrion -Friedel-Crafis arylarion sequenre, viz 14 to 15. to esmblish the triryrlir carbon framework.

๐Ÿ“œ SIMILAR VOLUMES

A new approach to the pseudopterosins us
A new approach to the pseudopterosins using an arene alkylation with a ฮณ-methylene-ฮณ-butyrolactone
โœ David C Harrowven; Jonathan D Wilden; Melloney J Tyte; Michael B Hursthouse; Sim ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Elsevier Science ๐ŸŒ French โš– 87 KB

A short and practical route to the tricyclic core of an unnatural pseudopterosin diastereoisomer is presented. Key features are an arene alkylation with a g-methylene-g-butyrolactone, viz. 1014, and an elaborate reduction sequence 1417 which both proceed diastereoselectively.

A synthetic approach to the plakortones
A synthetic approach to the plakortones
โœ Christian Bittner; Andrea Burgo; Patrick J. Murphy; Chi.H. Sung; Andrew J. Thorn ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ French โš– 127 KB
A synthetic approach to the mitosenes
A synthetic approach to the mitosenes
โœ J. Rebek Jr.; J.-C.E. fsGehret ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› Elsevier Science ๐ŸŒ French โš– 114 KB

Mitosenes, the chemical degradation products of the mitomycins, 1 are synthetically accessible through a number of approaches which build the pyrrolisidine system onto an existing 6membered ring. 2 We offer here an alternative, rapid assembly of the ring system, from which access to optically activ